Regal Assets Analytics

SanaCurrents Updates

SanaCurrents holding BioCryst (BCRX) shares into December 3 PDUFA

By |2020-12-02T10:26:29-05:00December 2nd, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

The FDA will decide on December 3 whether to approve [...]

SanaCurrents closing out Adverum Biotechnologies (ADVM)

By |2020-11-21T11:33:39-05:00November 17th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

Adverum Biotechnologies (NASDAQ:ADVM) on Saturday reported positive results from its [...]

Adverum catalyst set for Saturday, November 14

By |2020-11-17T10:16:00-05:00November 11th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

Adverum Biotechnologies (NASDAQ:ADVM) said it will present additional clinical data [...]

Calliditas’ Shares Soar About 35% After Hitting Catalyst

By |2020-11-09T12:00:46-05:00November 9th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

Sweden-based Calliditas Therapeutics’ (NASDAQ:CALT) delivered on its phase III trial [...]

FDA Places Partial Clinical Hold on Molecular Templates Trial; SanaCurrents Suspending Coverage

By |2020-11-06T10:39:56-05:00November 6th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Updates|Tags: |

In an earnings release after the market closed on November [...]

Forma releases positive data on phase II SanaCurrents catalyst; Position Closed Out

By |2020-10-26T16:16:47-04:00October 26th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Updates|Tags: |

Forma Therapeutics (NASDAQ:FMTX) reported on Monday its phase II trial [...]

Go to Top